Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT05064267
Eligibility Criteria:
Inclusion Criteria:
* Pediatric patients ages 6 months - 17 years
* Currently followed in the CKD clinic at Children's Healthcare of Atlanta (CHOA)
* Diagnosed with Stage 3, Stage 4 or Stage 5 CKD
* Must have routine venous laboratory tests planned as a component of their clinic encounter.
Exclusion Criteria:
* Participants \<13.6kg (to allow for safe blood sample volumes).
* History of venous thromboembolism, post solid organ transplant, co-diagnosis of inflammatory disease, and nephritis.
* Personal or family history of inherited thrombophilia conditions
* Hospital admission within the last 30 days.
* Transfusion (PRBC, FFP, Platelets, or Cryoprecipitate) within the last 30 days.
* Those on the following medications: steroids and anti-coagulants.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
17 Years
Study:
NCT05064267
Study Brief:
Protocol Section:
NCT05064267